|
|
Dr. Tien-Tsai Cheng |
|
Language Specialty - Rheumatology
- Immunology
- Internal Medicine
- Osteoporosis
Education - Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taiwan
Experience - 1990~2002 and 2012~2015 Director, Division of Allergy, Immunology and Rheumatology, Chang Gung Memorial Hospital at Kaohsiung, Taiwan
- 1997~ Chief of Medicine intensive care unit, Chang Gung Memorial Hospital at Kaohsiung, Taiwan
- 1998~Present Supervisor of The Taiwanese Osteoporosis Association, Taiwan
- 2001~2007, 2012~2016 Director of Rheumatology Association R.O.C, Taiwan
- 2008~2011 Secretary-general of Rheumatology Association R.O.C,
Certification - Rheumatology Association R.O.C Specialist, NO 121
- The Chinese Society of Immunology Specialist, NO 120
- Taiwan Society of Critical Care Medicine Specialist, NO SC0669
- Taiwan Society of Internal Medicine Specialist, NO 002123
Academic - Yu SF, Chen JF, Chen YC, Lai HM, Ko CH, Chiu WC, Su FM, Hsu CY, Su BY, Wu CH, Cheng TT. “Beyond bone mineral density, FRAX-based tailor-made intervention thresholds for therapeutic decision in subjects on glucocorticoid: A nationwide osteoporosis survey.” Medicine (Baltimore). 2017 Feb;96(5):e5959
- Hsu CY, Lin MS, Su YJ, Cheng TT, Lin YS, Chen YC, Chiu WC, Chen TH. “Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case-control study.” Rheumatology (Oxford). 2016 Dec 30. pii: kew457.
- Chen YC, Su FM, Cheng TT, Lai HM, Yu SF. “Is Long-Term Anti-Osteoporotic Treatment Associated with Greater Risk of Cancer in People with Severe Vertebral Fractures? A Hospital-Based Cohort Study.” Am Geriatr Soc. 2015 Nov;63(11):2418-9.
- Su FM, Chen YC, Cheng TT, Lin WC, Lui CC.“Is raloxifene associated with lower risk of mortality in postmenopausal women with vertebral fractures after vertebroplasty?: A hospital-based analysis.” BMC Musculoskelet Disord. 2015 Aug 19;16:209.
- Su FM, Liu DH, Chen JF, Yu SF, Chiu WC, Hsu CY, Ko CH, Tsai CC, Cheng TT.“Development and Validation of an Osteoporosis Self-Assessment Tool for Taiwan (OSTAi) Postmenopausal Women-A Sub-Study of the Taiwan OsteoPorosis Survey (TOPS).” PLoS One. 2015 Jun 18;10(6): e0130716.
- Chen YC, Su FM, Cheng TT, Lin WC, Lui CC. “Can antiosteoporotic therapy reduce mortality in MRI-proved acute osteoporotic vertebral fractures?” J Bone Miner Metab. 2016 May;34(3): 325-30.
- Lin KM, Cheng TT, Lin JC, Chen CJ. “Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.” Clin Rheumatol. 2015 Jun;34(6):1039-46.
- Su YJ, Cheng TT, Chen CJ, Chang WN, Tsai NW, Kung CT, Wang HC, Lin WC, Huang CC, Chang YT, Su CM, Chiang YF, Cheng BC, Lin YJ, Lu CH.“Investigation of the caspase-dependent mitochondrial apoptotic pathway in mononuclear cells of patients with systemic Lupus erythematosus.” J Transl Med. 2014 Nov 6;12:303.
- Hsu CY, Chiu WC, Chen JF, Chou CL, Su YJ, Yu SF, Cheng TT. “Medical specialty-related adherence to anti-osteoporotic regimens in fragility hip fracture patients.” J Bone Miner Metab. 2015 Sep;33(5): 577-83.
- Su YJ, Cheng TT, Chen CJ, Chiu WC, Chang WN, Tsai NW, Kung CT, Lin WC, Huang CC, Chang YT, Su CM, Chiang YF, Cheng BC, Lu CH. “The association among antioxidant enzymes, autoantibodies, and disease severity score in systemic lupus erythematosus: comparison of neuropsychiatric and nonneuropsychiatric groups.” Biomed Res Int. 2014;2014:137231
|
|
|